Literature DB >> 26202633

Yttrium-90 radioembolization for hepatocellular carcinoma in hepatitis B: commentary on a 103-patient Asian cohort.

Laura Kulik1, Riad Salem2.   

Abstract

Entities:  

Year:  2014        PMID： 26202633     DOI： 10.1007/s12072-014-9560-6

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  22 in total

1.  Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.

Authors:  Philip Hilgard; Monia Hamami; Amr El Fouly; André Scherag; Stefan Müller; Judith Ertle; Till Heusner; Vito R Cicinnati; Andreas Paul; Andreas Bockisch; Guido Gerken; Gerald Antoch
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

2.  Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

Authors:  Bruno Sangro; Livio Carpanese; Roberto Cianni; Rita Golfieri; Daniele Gasparini; Samer Ezziddin; Philipp M Paprottka; Francesco Fiore; Mark Van Buskirk; Jose Ignacio Bilbao; Giuseppe Maria Ettorre; Rita Salvatori; Emanuela Giampalma; Onelio Geatti; Kai Wilhelm; Ralf Thorsten Hoffmann; Francesco Izzo; Mercedes Iñarrairaegui; Carlo Ludovico Maini; Carlo Urigo; Alberta Cappelli; Alessandro Vit; Hojjat Ahmadzadehfar; Tobias Franz Jakobs; Secondo Lastoria
Journal:  Hepatology       Date:  2011-06-30       Impact factor: 17.425

3.  Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma.

Authors:  Masatoshi Kudo; Kazuho Imanaka; Nobuyuki Chida; Kohei Nakachi; Won-Young Tak; Tadatoshi Takayama; Jung-Hwan Yoon; Takeshi Hori; Hiromitsu Kumada; Norio Hayashi; Shuichi Kaneko; Hirohito Tsubouchi; Dong Jin Suh; Junji Furuse; Takuji Okusaka; Katsuaki Tanaka; Osamu Matsui; Michihiko Wada; Iku Yamaguchi; Toshio Ohya; Gerold Meinhardt; Kiwamu Okita
Journal:  Eur J Cancer       Date:  2011-09       Impact factor: 9.162

4.  Sorafenib therapy for hepatocellular carcinoma prior to liver transplant is associated with increased complications after transplant.

Authors:  Aimee E Truesdale; Stephen H Caldwell; Neeral L Shah; Curtis K Argo; Abdullah M S Al-Osaimi; Timothy M Schmitt; Patrick G Northup
Journal:  Transpl Int       Date:  2011-07-21       Impact factor: 3.782

5.  Survival and pattern of tumor progression with yttrium-90 microsphere radioembolization in predominantly hepatitis B Asian patients with hepatocellular carcinoma.

Authors:  Andrew Yu-Keat Khor; Ying Toh; John Carson Allen; David Chee-Eng Ng; Yung-Hsiang Kao; Guili Zhu; Su-Pin Choo; Richard Hoau-Gong Lo; Kiang-Hiong Tay; Jin-Yao Teo; Brian Kim-Poh Goh; Mark Christiaan Burgmans; Farah Gillian Irani; Anthony Soon-Whatt Goh; Pierce Kah-Hoe Chow
Journal:  Hepatol Int       Date:  2014-04-05       Impact factor: 6.047

6.  Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies.

Authors:  Bang-Bin Chen; I-Lun Shih; Chih-Horng Wu; Chiun Hsu; Chien-Hung Chen; Tiffany Ting-Fang Shih; Kao-Lang Liu; Po-Chin Liang
Journal:  J Vasc Interv Radiol       Date:  2014-01-24       Impact factor: 3.464

7.  Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression.

Authors:  Khairuddin Memon; Laura Kulik; Robert J Lewandowski; Mary F Mulcahy; Al B Benson; Daniel Ganger; Ahsun Riaz; Ramona Gupta; Michael Vouche; Vanessa L Gates; Frank H Miller; Reed A Omary; Riad Salem
Journal:  J Hepatol       Date:  2012-09-18       Impact factor: 25.083

8.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

9.  Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy.

Authors:  Michael Vouche; Ali Habib; Thomas J Ward; Edward Kim; Laura Kulik; Daniel Ganger; Mary Mulcahy; Talia Baker; Michael Abecassis; Kent T Sato; Juan-Carlos Caicedo; Jonathan Fryer; Ryan Hickey; Elias Hohlastos; Robert J Lewandowski; Riad Salem
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

10.  Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma.

Authors:  Spiros P Hiotis; Nuh N Rahbari; Gerald A Villanueva; Eunjie Klegar; Wei Luan; Qin Wang; Herman T Yee
Journal:  BMC Gastroenterol       Date:  2012-06-08       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.